Astellas Pharma, Inc. (4503)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Astellas Pharma, Inc. (4503)
Go deeper and ask any question about 4503
Company Performance
Current Price
as of Sep 17, 2024$12.01
P/E Ratio
173.74
Market Cap
$21.45B
Description
Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products focus on therapeutic fields that include transplantation, immunology, infectious diseases, urology, oncology, neuroscience, diabetic complications, and metabolic diseases. The firm's global brands include Prograf, Vesicare, Protopic, Harnal, and Funguard. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.
Metrics
Overview
- HQTokyo, TY
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- Ticker4503
- Price$12.013743-0.85%
Trading Information
- Market Cap$21.45B
- Float95.70%
- Average Daily Volume (1m)6,214,395
- Average Daily Volume (3m)7,163,081
- EPS$9.72
Company
- Revenue$1.70T
- Rev Growth (1yr)26.17%
- Net Income$37.60B
- Gross Margin73.34%
- EBITDA Margin21.89%
- EBITDA$103.57B
- EV$3.65T
- EV/Revenue2.15
- P/E173.74
- P/S1.78
Documents
Factset Street Account
Factset